AGIOS PHARMACEUTICALS, INC. (AGIO)
Clinical trial NCT05031780: enrollment: not set → 286 participants.
Clinical trial NCT05031780: enrollment: not set → 286 participants.
Clinical trial NCT06930508 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-06-01 → 2026-05-28 3. completion date: 2026-06-30 → 2026-07-31 4. primary completion date: 2026-06-30 → 2026-07-31 5. enrollment: not set → 83 participants
Clinical trial NCT05515406 updates: 1. status: ACTIVE_NOT_RECRUITING → TERMINATED 2. completion date: 2027-12-01 → 2025-08-13 3. primary completion date: 2027-12-01 → 2025-08-13 4. enrollment: not set → 9 participants
Clinical trial NCT07037433: enrollment: not set → 12800 participants.
Clinical trial NCT07446010 updates: 1. start date: 2026-05-29 → 2026-09-01 2. completion date: 2026-12-31 → 2027-09-30 3. primary completion date: 2026-12-31 → 2027-09-30 4. enrollment: not set → 33 participants
Clinical trial NCT07136012: enrollment: not set → 11000 participants.
Clinical trial NCT07037758: enrollment: not set → 380 participants.
Clinical trial NCT06788964: enrollment: not set → 29 participants.
Clinical trial NCT06852963 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2028-03-03 → 2028-04-21 3. primary completion date: 2028-01-30 → 2028-03-08 4. enrollment: not set → 17 participants
Clinical trial NCT06235983 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2027-04-01 → 2026-03-30 3. primary completion date: 2026-04-01 → 2025-07-02 4. enrollment: not set → 12 participants